APA (7th ed.) Citation

S, L., H, C., M, G., L, F., F, Z., J, G., . . . D, T. (2025). ADAMs contribute to triple negative breast cancer via mTORC1 pathway: Targeting ADAM-mTOR axis improves efficacy. Cancer letters, 626, 217775. https://doi.org/10.1016/j.canlet.2025.217775

Chicago Style (17th ed.) Citation

S, Liu, et al. "ADAMs Contribute to Triple Negative Breast Cancer via MTORC1 Pathway: Targeting ADAM-mTOR Axis Improves Efficacy." Cancer Letters 626 (2025): 217775. https://doi.org/10.1016/j.canlet.2025.217775.

MLA (9th ed.) Citation

S, Liu, et al. "ADAMs Contribute to Triple Negative Breast Cancer via MTORC1 Pathway: Targeting ADAM-mTOR Axis Improves Efficacy." Cancer Letters, vol. 626, 2025, p. 217775, https://doi.org/10.1016/j.canlet.2025.217775.